Key facts
- BioAlert Solutions’s last known valuation is $5.3M (Nov 2019).
- It has raised $4.1M; the latest was Later Stage VC ($1.7M) in Mar 2025.
- Notable investors include Québec Tech, Cycle Capital Management, Fondaction, Natural Products Canada, GreenSky Ventures — 8 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 8 names
- ·Watchlist + deal alerts for BioAlert Solutions
- ·The full record, as it builds
Funding rounds
No funding rounds for BioAlert Solutions are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About BioAlert Solutions
Developer of a water quality monitoring device designed to control the proliferation of pathogens in industrial waters. The company's device detects the presence of bacteria directly at the cooling system site, can be controlled by a remote and sends alarm signals directly to the person in charge, enabling businesses to have a reliable and economical monitoring alternative.
- Sector
- Information Technology
- HQ
- Sherbrooke, Canada
- Founded
- 2014
- Employees
- 27
- Website
- bioalert.ca/
- Ownership
- Privately Held (backing)
BioAlert Solutions doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in BioAlert Solutions shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on BioAlert Solutions in its N-PORT filings yet. We sweep new filings monthly.